Entecavir
Links shared publicly online about this topic
Entecavir Approval for Hepatitis B Expanded : Hospitalist News
ehospitalistnews.com — “Entecavir Approval for Hepatitis B Expanded : Hospitalist News” View full resource at ehospitalistnews.com
Most Recently Shared on October 28, 2010 at 5:25 pm By:
Bob Finn - Medical News Net Health News
#Entecavir Approval for #Hepatitis B Expanded. By @elizmech for Hospitalist News http://bit.ly/cw4AJ0
HCV New Drug Research: Entecavir Approval for Hepatitis B Expanded
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Entecavir Approval for Hepatitis B Expanded” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on October 31, 2010 at 12:34 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Entecavir Approval for Hepatitis B Expanded http://goo.gl/fb/5EYSU
Treatment for HBV infection with entecavir followed by lamivudine results in virologic rebound
news-medical.net — “A two-year trial of entecavir followed by lamivudine (LAM) in patients with chronic hepatitis B virus (HBV) infection resulted in a virologic rebound rate of 24% and 12% drug-resistance rate. Patients who continued on entecavir therapy throughout the study period had undetectable HBV DNA at the two-year endpoint. Details of this trial are published in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.” View full resource at news-medical.net
Most Recently Shared on April 1, 2011 at 4:59 am By:
Treatment for HBV infection with entecavir followed by lamivudine results in virologic rebound: A two-year trial... http://bit.ly/fPi8Wf
Entecavir Achieves High Response Rate In Real-life Clinical Management Of Patients With Chronic Hepatitis B
medicalnewstoday.com — “The nucleoside analogue entecavir (baraclude, bristol-myers squibb) achieves a high response rate and progressive decline in liver stiffness in patients with chronic hepatitis b, according to res” View full resource at medicalnewstoday.com
Most Recently Shared on November 4, 2009 at 8:25 pm By:
Entecavir Achieves High Response Rate In Real-life Clinical Management Of Patients With Chronic He.. http://bit.ly/3E8wTh #health_news
BARACLUDE(R) (entecavir) Approved By The European Commission For The Treatment Of Chronic Hepatitis B In Adult Patients
medicalnewstoday.com — “Bristol-Myers Squibb (NYSE: BMY) announced that BARACLUDE(R) (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients wit” View full resource at medicalnewstoday.com
Most Recently Shared on March 2, 2011 at 12:05 pm By:
BARACLUDE(R) (entecavir) Approved By The European Commission For The Treatment Of Chronic Hepatitis B In Adult Patients http://mnt.to/3RLW
BARACLUDE(R) (Entecavir) Approved By The European Commission For The Treatment Of CHB In Adult Patients With Evidence Of Decompensated Liver Disease
medicalnewstoday.com — “Bristol-Myers Squibb (NYSE:BMY) announced that BARACLUDE® (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients wi” View full resource at medicalnewstoday.com
Most Recently Shared on March 2, 2011 at 9:05 am By:
BARACLUDE(R) (Entecavir) Approved By The European Commission For The Treatment Of CHB In Adult Patients With Evidence ... http://mnt.to/3RKX
Entecavir Shows Promise as First-Line Drug for Chronic HBV - QualityPoint Technologies
qualitypointtech.net — “A small group of patients on long term entecavir (Baraclude) for chronic hepatitis B have had lasting viral suppression and regression of advanced cirrhosis, a new report indicates. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on March 22, 2011 at 4:35 am By:
Entecavir Shows Promise as First-Line Drug for Chronic HBV: A small group of patients on long term entecavir (Bara... http://bit.ly/favWKt
U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease
drugs.com — “Baraclude (entecavir) is used for the treatment of chronic hepatitis B. Information from Drugs.com includes Baraclude side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 19, 2010 at 11:11 pm By:
Drugs and Devices OW OW Health
U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patie... http://bit.ly/clcQOM #drug
Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B - Scotto - 2011 - Liver International - Wiley Online Library
onlinelibrary.wiley.com — “Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B - Scotto - 2011 - Liver International - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on August 14, 2011 at 4:28 am By:
Tenofovir plus entecavir as rescue therapy for multidrugâ€resistant chronic hepatitis B: (Source: Liver Interna... http://t.co/LUUGEvy
Gastroenterology Article | Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance
mdlinx.com — “Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance” View full resource at mdlinx.com
Most Recently Shared on September 21, 2011 at 11:43 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine re... http://t.co/oBIw3PJc #GI
Long-term Entecavir Therapy Reverses Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B - QualityPoint Technologies
qualitypointtech.net — “A new study shows that long-term treatment with entecavir reverses fibrosis and cirrhosis in patients with chronic hepatitis B infection. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 25, 2010 at 4:27 pm By:
Long-term Entecavir Therapy Reverses Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A new study show... http://bit.ly/aY316P
Long-term Entecavir Therapy Reverses Fibrosis and Cirrhosis in Chronic Hepatitis B Patients - QualityPoint Technologies
qualitypointtech.net — “Substantial Histologic Improvement Achieved in 96% of Patients with Advanced Disease Researchers from this international study found that patients with chronic hepatitis B virus (HBV) infection who received at least 3 years of cumulative entecavir (antiviral) therapy achieved substantial histologic improvement and regression of fibrosis or cirrhosis. Full details of the study appear in the September issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association” View full resource at qualitypointtech.net
Most Recently Shared on August 17, 2010 at 12:48 pm By:
Long-term Entecavir Therapy Reverses Fibrosis and Cirrhosis in Chronic Hepatitis B Patients: Substantial Histologi... http://bit.ly/doE399
Hepatitis B Drug Fights Liver Fibrosis, Cirrhosis
webmd.com — “A new generation of antiviral drugs can help reverse liver fibrosis and even early cirrhosis in patients with chronic hepatitis B virus infection, and they continue to work for many years, new research suggests.” View full resource at webmd.com
Most Recently Shared on August 18, 2010 at 11:47 pm By:
Hepatitis B Drug Fights Liver Fibrosis, Cirrhosis: A new generation of antiviral drugs can help reverse liver fibr... http://bit.ly/dyeCJB
Baraclude Sanctioned for Severe Liver Disease - Drugs.com MedNews
drugs.com — “Bristol-Myers Squibb said Monday its liver drug Baraclude (entecavir) has received expanded approval from the U.S. Food and Drug Administration to treat chronic” View full resource at drugs.com
Most Recently Shared on October 19, 2010 at 6:49 am By:
Baraclude Sanctioned for Severe Liver Disease - http://bit.ly/bxQkPt
Medical News: HBV Damage Disappears With Long-Term Therapy - in Gastroenterology, Hepatitis from MedPage Today
medpagetoday.com — “Long-term treatment with entecavir (Baraclude) at least partially reverses cirrhosis and fibrosis in most chronic hepatitis B patients, according to extended follow-up of a clinical trial.” View full resource at medpagetoday.com
Most Recently Shared on August 18, 2010 at 3:41 pm By:
HBV Damage Disappears With Long-Term Therapy (CME/CE) (MedPage Today) -- Long-term treatment with entecavir (Baraclude).. http://dld.bz/suHY
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Bob Finn - Medical News Net
Bringing you the latest news from scientific meetings and the policy world. Check us out at www.internalmedicinenews.com
-
Tina Banwart - HepatitisCNewDrugs
-
News-Medical.Net
Medical News from Around the World
Advertisement
